lacosamide / Generic mfg. 
Welcome,         Profile    Billing    Logout  

10 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lacosamide / Generic mfg.
2013-001834-16: EVALUATION OF SEIZURE CONTROL AND QUALITY OF LIFE IN PATIENTS WITH BRAIN TUMOR RELATED EPILEPSY TREATED WITH LACOSAMIDE AS ADD-ON THERAPY: A PROSPECTIVE EXPLORATIVE STUDY VALUTAZIONE DEL CONTROLLO DELLE CRISI E DELLA QUALITA’ DI VITA IN PAZIENTI AFFETTI DA EPILESSIA SECONDARIA A NEOPLASIA CEREBRALE IN TRATTAMENTO CON LACOSAMIDE (Vimpat®) IN ADD-ON : STUDIO PROSPETTICO ESPLORATIVO

Ongoing
4
40
Europe
Tablet, VIMPAT
ISTITUTI FISIOTERAPICI OSPITALIERI, UCB Pharma
PATIENTS WITH BRAIN TUMOR RELATED EPILEPSY PAZIENTI CON EPILESSIA SECONDARIA A NEOPLASIA CEREBRALE, PATIENTS WITH BRAIN TUMOR RELATED EPILEPSY PAZIENTI CON EPILESSIA SECONDARIA A NEOPLASIA CEREBRALE, Diseases [C] - Nervous System Diseases [C10]
 
 
VALUE, NCT02408549 / 2012-001770-29: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Completed
3
239
Europe, Japan, US, RoW
Lacosamide Tablet, Vimpat, LCM, Lacosamide Oral Solution
UCB BIOSCIENCES, Inc.
Epilepsy
03/23
03/23
NCT04627285 / 2020-001478-30: A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment

Active, not recruiting
3
48
Europe, RoW
Lacosamide
UCB Biopharma SRL
Epilepsy
07/25
07/25
2019-000755-14: Trial in healthy subjects to investigate the effect of analgesic drug on pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity. Studio su soggetti sani volto ad indagare gli effetti di farmaci analgesici sulla elaborazione del dolore mediante misure neurofisiologiche del'attività del midollo del midollo spinale e del tronco dell'encefalo

Ongoing
2
56
Europe
pregabalin, lacosamide, tapentadol, [N03AX16], [N/A], [N02AX06], Capsule, hard, Film-coated tablet, Tablet, LYRICA - 75 MG CAPSULA RIGIDA - USO ORALE 100 CAPSULE IN BLISTER IN UNITA' SEPARABILI PERFORATO (PVC/ALU), VIMPAT - 100 MG - COMPRESSE RIVESTITE CON FILM - USO ORALE - BLISTER (PVC/PVDC/ALU) 14 COMPRESSE, PALEXIA - 50 MG COMPRESSE RIVESTITE CON FILM 10 COMPRESSE IN BLISTER PVC/PVDC/AL
UMBERTO I - POLICLINICO DI ROMA, Teva Pharmaceutical Industries LTD, Innovative Medicines Initiative 2 (IMI2) Joint Undertaking under grant agreement, Eli Lilly and Company LTD, Esteve Pharmaceuticals SA, Grünenthal GmbH
Healthy volunteers (intended indication: pain) soggetti sani (indicazione: dolore), Healthy volunteers (intended indication: pain) soggetti sani (indicazione: dolore), Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
2019-000942-36: The effects of lacosamide, pregabalin and tapentadol on biomarkers of peripheral pain processing

Not yet recruiting
2
60
Europe
lacosamide, Pregabalin, Tapentadol, [N02AX06], [N/A], [N03AX16], Tablet, Capsule, Vimpat 100 mg film coated tablets, Lyrica 75 mg hard capsules, Palexia 50 mg film-coated tablets
Aarhus University, UMBERTO I - POLICLINICO DI ROMA, Innovative Medicines Initiative 2 (IMI2) Joint Undertaking under grant agreement, Eli Lilly and Company LTD, Esteve Pharmaceuticals SA, Grünenthal GmbH, Teva Pharmaceutical Industries LTD
Healthy volunteers (intended indication: pain), Study in healthy volunteers to examine drug effects on biomarkers in experimental pain, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
2019-001204-37: The effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processing

Not yet recruiting
2
56
Europe
lacosamide, pregabalin, tapentadol, [N02AX06], [N03AX16], [N/A], Film-coated tablet, Capsule, Tablet, Vimpat 100mg film coated tablets, Lyrica 75 mg hard capsules, Palexia 50 mg film-coated tablets
Institute of Neuroscience (IoNS), Université catholique de Louvain, UMBERTO I - POLICLINICO DI ROMA, Innovative Medicines Initiative 2 (IMI2) Joint Undertaking under Grant Agreement, Eli Lilly and Company LTD, Esteve Pharmaceuticals SA, Grünenthal GmBH, Teva Pharmaceutical Industries LTD
Healthy subjects (intended indication: pain), Study in healthy subjects to examine drug effects on biomarkers in experimental pain, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
2019-000908-15: The effects of lacosamide, pregabalin and tapentadol on pain processing

Not yet recruiting
2
36
Europe
lacosamide, Pregabalin, Tapentadol, Tablet, Capsule, Vimpat 100 mg film coated tablets, Lyrica 75 mg hard capsules, Palexia 50 mg film-coated tablets
Aarhus University, Innovatice Medicines Initiative 2 (IMI2) Joint Undertaking under grant agreement, Eli Lilly and Company LTD, Esteve Pharmaceutical Industries LTD, Grünenthal GmbH, Teva Pharmaceutical Industries LTD
Healthy volunteers (intended indication: pain), Study in healthy volunteers to examine drug effects on biomarkers in experimental pain, Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
 
 
LENS, NCT04519645 / 2020-001066-10: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Recruiting
2
32
Canada, US, RoW
Lacosamide intravenous, LCM, Lacosamide oral, Active Comparator
UCB Biopharma SRL
Electroencephalographic Neonatal Seizures, Epilepsy
08/25
08/25
NCT03559673: Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

No Longer Available
N/A
NA
Lacosamide, Vimpat
UCB Biopharma S.P.R.L.
Epilepsies, Partial
 
 
NCT04737837: A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Not yet recruiting
N/A
200
RoW
lacosamide, Xinkang
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Epilepsy, Focal-Onset Seizure
11/21
02/22

Download Options